Our Commitment to Patients
CRISPR Therapeutics is developing gene-based medicines with the potential to transform the lives of people with serious diseases. This mission defines our company, unites our teams, and inspires our work.
We are ready to break through, together.
At CRISPR Therapeutics, we approach patient advocacy by:
We listen to patient communities to gain a more complete understanding of serious diseases and their impact on patients’ lives.
We inform patient communities about our research when possible and appropriate, while following guidelines and regulations that govern our industry.
We foster relationships with patient communities and organizations based on transparency, compassion, and respect.
Patient organizations bring together communities, educate patients, and help advocate for research, funding, and treatments. CRISPR Therapeutics is proud to work with patient organizations and find ways to partner with them to accelerate progress toward our shared goals.
Many patient organizations are credible and reliable sources of information and patient support, including the groups listed below. CRISPR Therapeutics provides these links as a resource but does not endorse specific patient organizations or their communications.
- Cooley’s Anemia Foundation
- Sick Cells
- Sickle Cell Consortium
- Sickle Cell Disease Association of America, Inc.
- Sickle Cell Disease Coalition
- Cutaneous Lymphoma Foundation
- Leukemia & Lymphoma Society
- Lymphoma Research Foundation
- T-Cell Leukemia Lymphoma Foundation
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.